AlphaMaven AlphaMaven

Analysts Offer Insights on Real Estate Companies: Equinix (EQIX), National Health Investors (NHI) and NorthWest Healthcare Properties REIT (OtherNWHUF)

Reported by Theglobeandmail
Aug 15, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • National Health Investors (NHI) maintains analyst consensus of "Moderate Buy" with a $84.00 price target, implying 17.9% upside from current levels as of August 15, 2026.
  • • Equinix (EQIX) received a Buy rating from HSBC analyst Phani Kanumuri with a $1,400.00 price target; the Street consensus is "Strong Buy" with a $1,231.00 average target, representing 14.7% upside from the $1,073.78 closing price on the prior Thursday.
  • • TipRanks PerPlexity upgraded Equinix to Buy on August 7, 2026 with a $1,178.00 price target, supporting broader bullish sentiment in the data center sector.
  • • NorthWest Healthcare Properties REIT (NWHUF) is included in the analyst coverage cluster but limited detail was available on specific ratings and targets as of this reporting date.
  • • Analyst coverage spans the real estate sector across data centers (Equinix), healthcare properties REITs (National Health Investors and NorthWest Healthcare), reflecting institutional focus on inflation-resistant, dividend-yielding real estate segments.
Summary
Analysts have recently issued ratings and price targets across three prominent real estate investment trusts, signaling mixed but generally constructive sentiment in the sector. The coverage encompasses distinct real estate subsectors: data center infrastructure, senior housing, and healthcare properties.

National Health Investors, a REIT focused on healthcare properties including senior housing and sale-leaseback arrangements, maintains a "Moderate Buy" consensus rating among analysts tracking the stock. The consensus price target of $84.00 represents potential upside of 17.9%, suggesting institutional analysts see value in the company's healthcare real estate portfolio despite broader market volatility.

Equinix, the global data center operator, has attracted more bullish analyst attention. HSBC analyst Phani Kanumuri maintained a Buy rating with a $1,400.00 price target on the stock, which closed at $1,073.78 on the prior Thursday. Kanumuri's track record shows an average return of 6.4% on Equinix recommendations. More broadly, the Street consensus for Equinix is "Strong Buy" with an average price target of $1,231.00, implying 14.7% upside from prevailing levels. This bullish outlook was reinforced when TipRanks PerPlexity upgraded the stock to Buy with a $1,178.00 price target on August 7, 2026, reflecting strong demand for data center capacity driven by artificial intelligence infrastructure buildout and cloud computing expansion.

NorthWest Healthcare Properties REIT rounds out the analyst coverage cluster, though specific ratings and targets for this Canadian-listed healthcare properties REIT were not detailed in the available reporting. The inclusion of three diverse real estate plays in coordinated analyst commentary reflects institutional focus on real estate segments perceived as defensive and inflation-resistant amid broader equity market uncertainty.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Theglobeandmail Analysts Offer Insights on Real Estate Companies: Equinix (EQIX), National Health Investors (NHI) and NorthWest Healthcare Properties REIT (OtherNWHUF)